Designed to boost sexual desire in women, the drug flibanserin, commonly referred to as “female Viagra,” was recently recommended by a Food and Drug Administration advisory panel. If approved, flibanserin would be the only drug on the market to treat sexual dysfunction in women. But critics say the drug is not very effective and has too many side effects. We?ll discuss the hunt for a “female viagra” and the complexities of female sexual desire.
"Female Viagra" Moves Closer to FDA Approval
(Christopher Furlong/Getty Images)
Guests:
Tami Rowen, obstetrician and gynecologist at the University of California, San Francisco
Thea Cacchioni, assistant professor of women's studies at the University of Victoria in British Columbia
Louanne Cole Weston, sex therapist
Sponsored